Despite receiving transplants at a younger age, children with ARPKD experience similar survival as other kidney transplant patients. Transplant success rates are very good, and more than 85-90 percent of patients experience a successful transplant in the first year. Grafts also typically last the same amount of time in PKD patients compared to other transplant recipients. Sometimes, the presence of cytotoxic antibodies, a substance in the blood, can cause the recipient’s body to reject the donated kidney, however this is largely dependent on both the donor and cross match conducted prior to transplant and not age.